Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation

被引:8
作者
Baker, GM
Martin, JE
Jang, R
Schroeder, TJ
Armitstead, JA
Myre, S
First, MR
机构
[1] Univ Cincinnati, Med Ctr, Dept Pharm, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Med Ctr, Dept Internal Med, Cincinnati, OH 45267 USA
[3] Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA
关键词
D O I
10.1016/S0041-1345(98)01349-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:4082 / 4084
页数:3
相关论文
共 8 条
[1]  
Danovitch G, 1996, TRANSPLANTATION, V61, P722
[2]  
DANOVITCH GM, 1995, KIDNEY INT, V48, pS93
[3]  
Gonwa TA, 1996, CLIN TRANSPLANT, V10, P128
[4]  
GRINYO J, 1995, LANCET, V345, P1321
[5]  
Keown P, 1996, TRANSPLANTATION, V61, P1029
[6]  
KEOWN PA, 1997, AM SOC TRANSPL PHYS
[7]   MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL-ALLOGRAFT RECIPIENTS [J].
SOLLINGER, HW .
TRANSPLANTATION, 1995, 60 (03) :225-232
[8]  
Sullivan SD, 1997, J AM SOC NEPHROL, V8, P1592